Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study

by Paolo Preziosa, Maria A Rocca, Georgios Markozannes, Marios C Pantzaris, Paola Valsasina, Nikolaos Grigoriadis, Christos Bakirtzis, Georgios Hadjigeorgiou, Efthimos Dardiotis, George Loucaides, Evangelia Ntzani, Savvas Omorfos, Roberta Messina, Ioannis Patrikios
Published 2022-11-01